Phosphoinositides Direct Equine Infectious Anemia Virus Gag Trafficking and Release

Traffic

Volumn 12, Issue 4, 2011, Pages 438-451

  Fernandes, Fiona ^a   Chen, Kang ^b   Ehrlich, Lorna S ^a   Jin, Jing ^c   Chen, Min H ^a   Medina, Gisselle N ^a   Symons, Marc ^d   Montelaro, Ronald ^e   Donaldson, Julie ^b   Tjandra, Nico ^b   Carter, Carol A ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Feinstein Institute   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bimolecular fluorescence complementation; EIAV; HIV 1; Multivesicular bodies; PI(3)P; PI(3,5)P2; PI(4,5)P2; VLP

Indexed keywords

5 PHOSPHATE IV; GAG PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 4,5 BIPHOSPHATE; SYNAPTOJANIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR TRANSPORT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; VIRUS ASSEMBLY; VIRUS LIKE AGENT; VIRUS MUTATION; VIRUS RELEASE;

ACID ANHYDRIDE HYDROLASES; AMINOPYRIDINES; ANIMALS; ANTIVIRAL AGENTS; CELL MEMBRANE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; GENE PRODUCTS, GAG; HETEROCYCLIC COMPOUNDS, 3-RING; HIV-1; HORSES; HUMANS; INFECTIOUS ANEMIA VIRUS, EQUINE; MUTATION; PHOSPHATIDYLINOSITOL PHOSPHATES; PROTEIN BINDING; PROTEIN TRANSPORT; TRANSFECTION; VIRUS ASSEMBLY;

EID: 79952613075     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/j.1600-0854.2010.01153.x     Document Type: Article

References (38)

1. Wills JW, Craven RC. Form, function, and use of retroviral gag proteins. AIDS 1991;5:639-654.
2. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO. Phosphatidylinositol (4, 5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc Natl Acad Sci U S A 2004;101:14889-14894.
3. Ono A, Freed EO. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J Virol 1999;73:4136-4144.
4. Facke M, Janetzko A, Shoeman RL, Krausslich HG. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J Virol 1993;67:4972-4980.
5. Gallina A, Mantoan G, Rindi G, Milanesi G. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein. Biochem Biophys Res Commun 1994;204:1031-1038.
6. Ono A, Demirov D, Freed EO. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. J Virol 2000;74:5142-5150.
7. Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc Natl Acad Sci U S A 2006;103:11364-11369.
8. Tang C, Loeliger E, Luncsford P, Kinde I, Beckett D, Summers MF. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc Natl Acad Sci U S A 2004;101:517-522.
9. Paillart JC, Gottlinger HG. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting. J Virol 1999;73:2604-2612.
10. Resh MD. A myristoyl switch regulates membrane binding of HIV-1 Gag. Proc Natl Acad Sci U S A 2004;101:417-418.
11. Chen K, Bachtiar I, Piszczek G, Bouamr F, Carter C, Tjandra N. Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2. Biochemistry 2008;47:1928-1937.
12. Provitera P, Bouamr F, Murray D, Carter C, Scarlata S. Binding of equine infectious anemia virus matrix protein to membrane bilayers involves multiple interactions. J Mol Biol 2000;296:887-898.
13. Puffer BA, Watkins SC, Montelaro RC. Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly. J Virol 1998;72:10218-10221.
14. Tanzi GO, Piefer AJ, Bates P. Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release. J Virol 2003;77:8440-8447.
15. Dumas JJ, Merithew E, Sudharshan E, Rajamani D, Hayes S, Lawe D, Corvera S, Lambright DG. Multivalent endosome targeting by homodimeric EEA1. Mol Cell 2001;8:947-958.
16. Kutateladze TG, Ogburn KD, Watson WT, de Beer T, Emr SD, Burd CG, Overduin M. Phosphatidylinositol 3-phosphate recognition by the FYVE domain. Mol Cell 1999;3:805-811.
17. Odorizzi G, Babst M, Emr SD. Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell 1998;95:847-858.
18. Guo S, Stolz LE, Lemrow SM, York JD. SAC1-like domains of yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases. J Biol Chem 1999;274:12990-12995.
19. Schmid AC, Wise HM, Mitchell CA, Nussbaum R, Woscholski R. Type II phosphoinositide 5-phosphatases have unique sensitivities towards fatty acid composition and head group phosphorylation. FEBS Lett 2004;576:9-13.
20. Jefferies HB, Cooke FT, Jat P, Boucheron C, Koizumi T, Hayakawa M, Kaizawa H, Ohishi T, Workman P, Waterfield MD, Parker PJ. A selective PIKfyve inhibitor blocks PtdIns(3, 5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep 2008;9:164-170.
21. Hatanaka H, Iourin O, Rao Z, Fry E, Kingsman A, Stuart DI. Structure of equine infectious anemia virus matrix protein. J Virol 2002;76:1876-1883.
22. Manders EMM, Verbeek FJ, Aten JA. Measurement of colocalization of objects in dual color confocal images. J Microsc 1993;169:375-382.
23. Varnai P, Thyagarajan B, Rohacs T, Balla T. Rapidly inducible changes in phosphatidylinositol 4, 5-bisphosphate levels influence multiple regulatory functions of the lipid in intact living cells. J Cell Biol 2006;175:377-382.
24. Lawe DC, Chawla A, Merithew E, Dumas J, Carrington W, Fogarty K, Lifshitz L, Tuft R, Lambright D, Corvera S. Sequential roles for phosphatidylinositol 3-phosphate and Rab5 in tethering and fusion of early endosomes via their interaction with EEA1. J Biol Chem 2002;277:8611-8617.
25. Kobayashi T, Startchev K, Whitney AJ, Gruenberg J. Localization of lysobisphosphatidic acid-rich membrane domains in late endosomes. Biol Chem 2001;382:3 [Short Communication].
26. Chan R, Uchil PD, Jin J, Shui G, Ott DE, Mothes W, Wenk MR. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J Virol 2008;82:11228-11238.
27. Kisseleva MV, Cao L, Majerus PW. Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits Akt/protein kinase B phosphorylation and leads to apoptotic cell death. J Biol Chem 2002;277:6266-6272.
28. Brown FD, Rozelle AL, Yin HL, Balla T, Donaldson JG. Phosphatidylinositol 4, 5-bisphosphate and Arf6-regulated membrane traffic. J Cell Biol 2001;154:1007-1017.
29. Aikawa Y, Martin TF. ARF6 regulates a plasma membrane pool of phosphatidylinositol(4, 5)bisphosphate required for regulated exocytosis. J Cell Biol 2003;162:647-659.
30. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994;269:5241-5248.
31. Chen C, Jin J, Rubin M, Huang L, Sturgeon T, Weixel KM, Stolz DB, Watkins SC, Bamburg JR, Weisz OA, Montelaro RC. Association of gag multimers with filamentous actin during equine infectious anemia virus assembly. Curr HIV Res 2007;5:315-323.
32. Jin J, Sturgeon T, Chen C, Watkins SC, Weisz OA, Montelaro RC. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays. J Virol 2007;81:11226-11235.
33. Medina G, Zhang Y, Tang Y, Gottwein E, Vana ML, Bouamr F, Leis J, Carter CA. The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101. Traffic 2005;6:880-894.
34. Demirov DG, Freed EO. Retrovirus budding. Virus Res 2004;106: 87-102.
35. Shkriabai N, Datta SA, Zhao Z, Hess S, Rein A, Kvaratskhelia M. Interactions of HIV-1 Gag with assembly cofactors. Biochemistry 2006;45:4077-4083.
36. Alfadhli A, Barklis RL, Barklis E. HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4, 5)-bisphosphate. Virology 2009;387:466-472.
37. Malecz N, McCabe PC, Spaargaren C, Qiu R, Chuang Y, Symons M. Synaptojanin 2, a novel Rac1 effector that regulates clathrin-mediated endocytosis. Curr Biol 2000;10:1383-1386.
38. Rusk N, Le PU, Mariggio S, Guay G, Lurisci C, Nabi IR, Corda D, Symons M. Synaptojanin 2 functions at an early step of clathrin-mediated endocytosis. Curr Biol 2003;13:659-663.